Mr. Allan R. Ferguson

• 
  www.biopure.com/shared/boardofdirectors.cfm?CDID=1&CPgI - [Cached Version]
  Published on: 12/16/2007    Last Visited: 12/16/2007  

  Allan Ferguson

• 
  www.corporate-ir.net/ireye/ir_site.zhtml?ticker=bpur&sc - [Cached Version]
  Published on: 1/26/2008    Last Visited: 1/26/2008  

  Allan Ferguson
  
  Director

• 
  www.sec.gov/Archives/edgar/data/879106/0001193125-08-07 - [Cached Version]
  Published on: 4/10/2008    Last Visited: 4/14/2008  

  Allan R. Ferguson
  ...
  Allan R. Ferguson,Mr.Ferguson is currently retired.Mr. Ferguson was Managing Director of 3i Technology Partners, an international venture capital group, from July 1999 until March 2007 and was head of its United States operations from August 2004 until March 2007.From April 1993 to July 1999, Mr. Ferguson was a General Partner of Atlas Venture, an international venture capital fund which invests in early stage technology and health care companies, and leader of its Life Science team.Mr. Ferguson is also a director of Biopure Corporation, TransMedics, Inc., Ulthera Inc., Xthetix, Inc. and ZONARE Medical Systems, Inc.
  ...
  D'Andrade, Ferguson and Fletcher are independent directors, as defined in Rule 4200 of the National Association of Securities Dealers' listing standards.

• 
  www.3i.com/media/press-releases/sbi_040106.html - [Cached Version]
  Published on: 1/4/2006    Last Visited: 9/12/2007  

  3i's Boston based head of US venture capital, Allan Ferguson and 3i's Paris based director Olivier Litzka are taking active board roles working with the company's proven management team to drive growth in the US and Europe.
  ...
  Allan Ferguson, said "I was pleased to work with my 3i colleagues in Paris, Lyon and Munich on this exciting venture, which clearly underscores the international dimensions of this enterprise.

• 
  www.3i.com/media/pr.xml - [Cached Version]
  Published on: 8/15/2005    Last Visited: 3/5/2007  

  This will increase cosmetic efficacy while also providing an improved safety profile," stated Allan Ferguson, Head of 3i US Venture Capital.

• 
  www.sec.gov/Archives/edgar/data/815508/0001193125-09-04 - [Cached Version]
  Published on: 3/3/2009    Last Visited: 3/4/2009  

  Allan R. Ferguson, 66, has served as a director of Biopure since April 4, 2007. Mr. Ferguson retired as a senior partner of the 3i Venture Capital Group, where he served until March 2007. He was also formerly a managing partner of Aspen Ventures and a general partner of Atlas Ventures. He is also a director of Autoimmune Inc. and TransMedics Inc.

• 
  www.sec.gov/Archives/edgar/data/815508/0001193125-08-03 - [Cached Version]
  Published on: 2/22/2008    Last Visited: 2/23/2008  

  Allan R. Ferguson, 65, has served as a director of Biopure since April 4, 2007.Mr. Ferguson retired as a senior partner of the 3i Venture Capital Group until March 2007.He was also formerly a managing partner of Aspen Ventures and a general partner of Atlas Ventures.He is also a director of Autoimmune Inc., TransMedics Inc., Ulthera Inc., Xthetix Inc. and ZONARE Medical Systems.
  ...
  Allan R. Ferguson(5)
  ...
  Mr. Ferguson's shares consist of 185,881 shares, exercisable warrants to purchase 174,943 shares and options exercisable 60 days from January 31, 2008 to purchase 3,666 shares.

• 
  www.sec.gov/Archives/edgar/data/1030573/0001180740-08-0 - [Cached Version]
  Published on: 9/16/2008    Last Visited: 9/17/2008  

  0001030573 FERGUSON ALLAN R C/O ATLAS VENTURE 222 BERKELEY STREET BOSTON MA 02116 1 0 0 0

• 
  www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/w - [Cached Version]
  Published on: 12/1/1988    Last Visited: 4/14/2007  

  Biopure Appoints Allan Ferguson to Its Board of DirectorsBiopure Appoints Allan Ferguson to Its Board of Directors
  ...
  Biopure Appoints Allan Ferguson to Its Board of Directors
  
  CAMBRIDGE, Mass., April 9 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) today announced the appointment of Allan Ferguson to the company's board of directors.He brings to the board over 25 years of operating and management experience in engineering, manufacturing, and research and development, and 20 years of experience in international venture capital investing with life science and technology companies. Ferguson is also a director of Autoimmune Inc., TransMedics Inc., Ulthera Inc., Xthetix Inc., and ZONARE Medical Systems.He recently retired as a senior partner of 3i's Venture Capital Group, where he headed up the firm's U.S. operation that he helped start.He previously served as a Biopure board member from December 1988 to December 1990, in connection with 3i's investment in the company. Ferguson was formerly a managing partner of Aspen Ventures and a general partner of Atlas Ventures, where he helped establish Atlas' healthcare practice.He has also held senior operating positions at Johnson
  ...
  Ferguson is a member of the New England Venture Capital Association

• 
  www.corporate-ir.net/ireye/ir_site.zhtml?ticker=bpur&sc - [Cached Version]
  Published on: 11/18/2007    Last Visited: 11/18/2007  

  Allan FergusonBiopure Investor Relations
  ...
  Allan Ferguson
  ...
  Allan Ferguson became a director of Biopure in April 2007.He brings to the board over 25 years of operating and management experience in engineering, manufacturing, and research and development, and 20 years of experience in international venture capital investing with life science and technology companies.
  
  Ferguson is also a director of Autoimmune Inc., TransMedics Inc., Ulthera Inc., Xthetix Inc., and ZONARE Medical Systems.He recently retired as a senior partner of 3i's Venture Capital Group, where he headed up the firm's U.S. operation that he helped start.He previously served as a Biopure board member from December 1988 to December 1990, in connection with 3i's investment in the company.
  
  Ferguson was formerly a managing partner of Aspen Ventures and a general partner of Atlas Ventures, where he helped establish Atlas' healthcare practice.He has also held senior operating positions at Johnson & Johnson, Ortho Diagnostics Systems Inc. and Damon Biotech, where he served as a managing director and senior vice president responsible for European operations.
  
  Ferguson is a member of the New England Venture Capital Association (NEVCA) and the National Association of Corporate Directors (NACD), and was previously a board member of the National Venture Capital Association (NVCA).He holds a B.S. in chemical engineering from the University of Delaware and attended the Harvard Executive Management program.

Page:  1 2 3 4 5